As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

2 Dividend Stocks to Buy Hand Over Fist in November was originally published by The Motley Fool Their recent issues are ...

Amgen refutes in a press release that its trial obesity drug, MariTide, may cause bone loss density. Amgen's stock has risen 4.6% this year against a decrease of 3.8% for the pharmaceuticals industry.

Discover why Amgen is a reliable wealth compounder with strong Q3 results, a promising pipeline, debt reduction, and ...

We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at ...

Amgen, a global biotechnology leader highlighting profound research and development capabilities and biomanufacturing, showcases its latest achievements in the field of innovative medicines under the ...

At the CIIE, Amgen brings six innovative products-focusing on cardiovascular ... The prevention and treatment of chronic diseases are one of Amgen's top priorities in building the Healthy China ...

We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now ... with a diverse portfolio of marketed and pipeline products. Amgen’s discovery pipeline had led the company to ...

Discover how Amgen is achieving a fully automated enterprise through strategic partnerships with Cognizant and UiPath to enhance efficiency.

Amgen (NASDAQ:AMGN – Free Report) had its target price cut by UBS Group from $335.00 to $326.00 in a report released on Thursday, Benzinga reports. They currently have a neutral rating on the medical ...

With increasing chronic diseases, demand for personalized medicines, and adoption of AI, the biotech market is booming.